U.S Critical Care Antibiotics Markets Increasing Incidence of Critical Care Infections and Bacterial Resistance Drives Market Growth “With instances of nosocomial infections - infections originating in hospitals - continuing to expand in numbers and intensities, there is a strong demand for effective critical care antibiotics.” Pharmaceutical Biotech Analyst Team Frost & Sullivan

Industry Trends Few multinational companies dominate with shrinking major brands per segment Decreasing in-patient/out-patient ratios with early transfer to community practice Group purchase organizational deals in hospitals with rapidly increasing reimbursement concerns Focused injectable antibiotics in critical care with oral options for step-down therapy Specialized hospital marketing / selling strategies

Key Features Frost & Sullivan provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics’ and emerging products in the critical care antibiotics markets Market sizing and competitive analysis Market forecasts and opportunity analysis End user analysis within each report

What We Offer Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans

Who Will Benefit? Current Market Participants Find out how you compare to the competition Assess current and future drivers and restraints Determine and exploit new market share opportunities New Entrants Analyze challenges associated with the industry Calculate time scales for strategy implementation Position yourself to capitalize on the market’s unmet needs Investment Community Analyze long-term strategies of companies in critical care antibiotics therapies markets Determine which participants will outperform the competition Assess attractiveness of investing in critical care antibiotics markets

What’s Included Total critical care antibiotics markets Critical care cephalosporins market Critical care quinolones market Critical care penicillins market Critical care carbapenems market Other critical care antibiotics market (including new classes)

Key Market Participants Abbott Laboratories AstraZeneca Pharmaceuticals LP. Aventis Pharmaceuticals, Inc. Bayer Pharmaceutical Division Bristol-Myers Squibb Co. Eli Lilly & Co. Fujisawa Healthcare, Inc. GlaxoSmithKline Johnson & Johnson King Pharmaceuticals, Inc. Lederle Labs Merck & Co., Inc. Pfizer, Inc. Pharmacia Corp. Roche Biosciences

Call toll free 877 G O F ROST ( ) Fax toll free Visit For More Information